Identification of HLA-DR9 (DRB1*0901)-binding peptide motifs using a phage fUSE5 random peptide library

被引:24
作者
Fujisao, S
Matsushita, S
Nishi, T
Nishimura, Y
机构
[1] KUMAMOTO UNIV,GRAD SCH MED SCI,DEPT NEUROSCI & IMMUNOL,DIV IMMUNOGENET,KUMAMOTO 860,JAPAN
[2] KUMAMOTO UNIV,SCH MED,DEPT NEUROSURG,KUMAMOTO 860,JAPAN
关键词
D O I
10.1016/0198-8859(95)00169-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We identified HLA-DRB1 *0901-binding peptides by affinity-based selection of a phage random peptide library using the biotinylated DR9 complex. Analogue peptides with single amino acid residue substitutions of a DR9 binder revealed that two major anchors (WxxS, where x is any amino acid) play an essential role in binding to DR9. Determination of the binding affinity of synthetic wild-type-based analogue peptides showed that substituting W to F or L, and S to A, V, or F allow high affinity binding with DR9. Collectively, DR9-binding peptide motifs identified in this study are characteristic in that (a) only two anchors of the NH2-terminal half of binding peptides play important roles in binding, and (b) small neutral hydrophilic Ser is allowed as the second anchor for high-affinity binding, unlike the other DR-binding motifs heretofore reported. The implications of our results are discussed in light of the HLA-DR9-associated susceptibility to juvenile-onset myasthenia gravis and systemic lupus erythematosus with antiphospholipid syndrome, in particular, T-cell responses to autoantigens.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 18 条
[1]  
BOEHNCKE WH, 1993, J IMMUNOL, V150, P331
[2]   ISOLATION AND CHARACTERIZATION OF ANTIGEN-IA COMPLEXES INVOLVED IN T-CELL RECOGNITION [J].
BUUS, S ;
SETTE, A ;
COLON, SM ;
JENIS, DM ;
GREY, HM .
CELL, 1986, 47 (06) :1071-1077
[3]   THE SET OF NATURALLY PROCESSED PEPTIDES DISPLAYED BY DR MOLECULES IS TUNED BY POLYMORPHISM OF RESIDUE-86 [J].
DEMOTZ, S ;
BARBEY, C ;
CORRADIN, G ;
AMOROSO, A ;
LANZAVECCHIA, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (02) :425-432
[4]   PROMISCUOUS AND ALLELE-SPECIFIC ANCHORS IN HLA-DR-BINDING PEPTIDES [J].
HAMMER, J ;
VALSASNINI, P ;
TOLBA, K ;
BOLIN, D ;
HIGELIN, J ;
TAKACS, B ;
SINIGAGLIA, F .
CELL, 1993, 74 (01) :197-203
[5]   PRECISE PREDICTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II PEPTIDE INTERACTION BASED ON PEPTIDE SIDE-CHAIN SCANNING [J].
HAMMER, J ;
BONO, E ;
GALLAZZI, F ;
BELUNIS, C ;
NAGY, Z ;
SINIGAGLIA, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2353-2358
[6]  
HIRAYAMA K, 1986, J IMMUNOL, V137, P924
[7]  
KOIDE Y, 1982, J IMMUNOL, V129, P1061
[8]  
KRIEGER JI, 1991, J IMMUNOL, V146, P2331
[9]   HLA ANTIGENS IN JAPANESE PATIENTS WITH MYASTHENIA-GRAVIS [J].
MATSUKI, K ;
JUJI, T ;
TOKUNAGA, K ;
TAKAMIZAWA, M ;
MAEDA, H ;
SODA, M ;
NOMURA, Y ;
SEGAWA, M .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (02) :392-399
[10]   ALLELE SPECIFICITY OF STRUCTURAL REQUIREMENT FOR PEPTIDES BOUND TO HLA-DRB1-ASTERISK-0405 AND HLA-DRB1-ASTERISK-0406 COMPLEXES - IMPLICATION FOR THE HLA-ASSOCIATED SUSCEPTIBILITY TO METHIMAZOLE-INDUCED INSULIN AUTOIMMUNE SYNDROME [J].
MATSUSHITA, S ;
TAKAHASHI, K ;
MOTOKI, M ;
KOMORIYA, K ;
IKAGAWA, S ;
NISHIMURA, Y .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :873-883